Skip to search formSkip to main contentSkip to account menu

Aurorix

Known as: Aurorex, Manerix, Moclamine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Moclobemide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Bioavailability of moclobemide from two formulation tablets in healthy humans.
A ,,sine qua non" requirement for a generic formulation to be admitted for a medical use is to provide bioavailability studies in… 
2006
2006
Ralentissement psychomoteur et dépression du sujet âgé : Place du moclobémide (Moclamine®)
La depression est une maladie frequente chez le sujet âge. Pourtant, elle reste sous-diagnostiquee et sous-traitee. En effet, la… 
2003
2003
Fatal combination of moclobemide overdose and whisky.
The antidepressant moclobemide (Aurorix) is a reversible inhibitor of monoamine oxidase-A. Pure moclobemide overdose is… 
2000
2000
The Pharmacology of Moclobemide and its Fatal Drug Interactions in Overdose
ABSTRACT Moclobemide (Manerix™) is one of the first reversible inhibitors of monoamine-A (RIMA). It inhibits metabolism of… 
Review
1999
Review
1999
Monoamine oxidase drugs and diet
Summary Aims: To review the literature on monoamine oxidase drugs and propose a simple diet sheet. Methods: A literature… 
1998
1998
[Administration of moclobemide++ in children with attention deficit hyperactivity disorder ].
ADHD is a frequent disorder that occurs among approximately 5-10% of school children. Treating this syndrome, pharmacotherapy… 
1997
1997
[Preventive treatment of migraine and chronic tension headache with moclobemide].
Tricyclic antidepressants have been used for a long time in migraine prophylaxis and in the treatment of chronic tension-type… 
1996
1996
Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice
1994
1994
Moclobemide (aurorix) in primary major depression
1990
1990
Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
The effect of reversible inhibitors of the monoamine oxidase type A (MAO-A), moclobemide (Aurorix) and Ro 41-1049 (20 mg/kg i.p… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)